Allergic rhinitis in children.

Area of Science:

• Pediatric Allergy and Immunology
• Otorhinolaryngology
• Clinical Therapeutics

Background:

• Allergic rhinitis affects up to 40% of children, frequently remaining undiagnosed.
• Effective management hinges on accurate symptom assessment for appropriate treatment selection.
• Allergen avoidance is often challenging in real-world scenarios.

Purpose of the Study:

• To review current therapeutic options for allergic rhinitis in children.
• To differentiate the efficacy of antihistamines versus intranasal steroids based on allergen type and symptom presentation.
• To discuss the role and limitations of immunotherapy in managing allergic rhinitis.

Main Methods:

• Literature review of studies on allergic rhinitis treatments in pediatric populations.
• Analysis of symptom profiles and their correlation with specific allergens (e.g., house dust mite, pollen).
• Comparison of treatment outcomes for antihistamines, intranasal steroids, and immunotherapy.

Main Results:

• Antihistamines provide limited relief for perennial allergens like house dust mite, particularly for nasal obstruction.
• Antihistamines are effective for pollen-induced symptoms such as nasal itch, rhinorrhoea, and sneezing.
• Intranasal steroids are the preferred treatment for persistent moderate-to-severe allergic rhinitis, outperforming antihistamines in relieving nasal obstruction.

Conclusions:

• Intranasal steroids are the mainstay for persistent allergic rhinitis, with efficacy dependent on proper usage and compliance.
• Immunotherapy presents a potentially effective but costly option for specific pollen allergies, though its benefit in house dust mite rhinitis is debated.
• Accurate diagnosis and tailored treatment strategies are crucial for managing pediatric allergic rhinitis effectively.